Study: Some heart patients undoing drug benefits

Mar 12, 2009 By MARIA CHENG , AP Medical Writer

(AP) -- European heart patients are taking more medication than ever before to lower their blood pressure and cholesterol, but bad habits such as overeating and smoking are undermining the drugs, a new study says. Despite big increases in heart patients on medication, most still have high blood pressure and nearly half have high cholesterol.

Researchers interviewed more than 8,500 in eight countries. Patients were on average about 60 years old, and had a history of problems.

The experts found that more young patients are smoking, and more patients are fatter and diabetic compared with similar groups from 12 years ago.

The study was published Friday in the medical journal, .

"In terms of the lifestyles of patients with , everything is moving in the wrong direction," said Dr. David Wood, one of the paper's authors and a professor of cardiovascular medicine at Imperial College in London.

The study was supported by the European Society of and paid for by pharmaceutical companies that make heart drugs.

Researchers also found that the numbers of patients taking drugs to lower their cholesterol was seven times higher in 2006-2007 than in 1995-1996. About 43 percent of patients still had .

And while more people now take medications to lower their , Wood said that hadn't made any difference. "The response of physicians is just to give more and more drugs, but what we need is a comprehensive lifestyle program."

Experts said trends were similar in the United States.

"Even if we advise patients to lose weight, they have to walk out the door and do that themselves," said Dr. Alfred Bove, incoming president of the American College of Cardiology.

Bove, who was not linked to the study, said more patients were now being treated for high blood pressure, but millions were unaware they even had a problem.

In the last decade, deaths due to heart disease have dropped by about 30 percent in the United States and 45 percent in Britain. But the rates are leveling off, and experts worry the surge in obesity and diabetes will reverse previous successes.

Even with advances such as medications, heart stents and angioplasties, Dr. Daniel Jones, a past president of the American Heart Association, said that fighting heart disease "is like swimming upstream."

Jones, who was not connected to the Lancet study, warned that the widespread use of heart drugs has masked the effects of the obesity epidemic and that it would be even worse without them.

"We know that giving medications will reduce patients' risk, but we shouldn't put all our eggs in that one basket," he said. "We need to work harder on preventing problems at their root."

--

On the Net:

http://www.lancet.com

http://www.americanheart.org

http://www.acc.org

http://www.escardio.org

©2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Explore further: Acne pill benefits outweigh blood clot risk: EU agency

add to favorites email to friend print save as pdf

Related Stories

Two Parkinson's drugs linked to valve risk

Jan 05, 2007

Two drugs used for Parkinson's disease increase the risk of heart-valve damage, studies said, prompting a U.S. official to call for a halt in their use.

Recommended for you

First influenza vaccine brought to clinical testing

17 hours ago

Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology AG today announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial with their ...

Aspirin not always best treatment for many individuals

May 16, 2013

(Medical Xpress)—An aspirin a day may not always keep heart disease away, say two University of Florida cardiologists. But a new algorithm they have developed outlines factors physicians should weigh as ...

FDA: lower ambien's dose to prevent drowsy driving

May 15, 2013

(HealthDay)—The U.S. Food and Drug Administration has approved new, lower-dose labeling for the popular sleep drug Ambien (zolpidem) in an effort to cut down on daytime drowsiness that could be a hazard ...

Simponi approved for ulcerative colitis

May 15, 2013

(HealthDay)—Simponi (golimumab) injection has been approved by the U.S. Food and Drug Administration to treat adults with moderate-to-severe ulcerative colitis.

FDA approves genetic test for lung cancer drug

May 14, 2013

The Food and Drug Administration says it approved a genetic test from Roche to help doctors identify patients who can benefit from a lung cancer drug made by Genentech.

User comments : 0

More news stories

Temporal processing in the olfactory system

The neural machinery underlying our olfactory sense continues to be an enigma for neuroscience. A recent review in Neuron seeks to expand traditional ideas about how neurons in the olfactory bulb might encode information about ...

US seizes Bitcoin operator accounts

US authorities seized the accounts of a Bitcoin digital currency exchange operator, claiming it was functioning as an "unlicensed money service business," court documents showed Friday.

Chinese, Indian airlines face EU pollution fines

Eight Chinese and two Indian airlines face fines of up to several million euros for not paying for their greenhouse gas emissions during flights within the bloc, the European Commission said on Friday.

Alaska volcano shoots ash 15,000 feet into the air

(AP)—One of Alaska's most restless volcanoes has shot an ash cloud 15,000 feet into the air in an ongoing eruption that has drawn attention from a nearby community but isn't expected to threaten air traffic.